Miron Ingrith, Miron Lucian, Lupu Vasile Valeriu, Ignat Ancuta
Pediatrics Department Oncology Department, University of Medicine and Pharmacy "Gr. T. Popa", Iasi, Romania.
Medicine (Baltimore). 2017 Jul;96(28):e7518. doi: 10.1097/MD.0000000000007518.
The Burkitt lymphoma (BL) is a very aggressive B-cell non-Hodgkin's lymphoma. It accounts for 34% of lymphoma cases in children.
We present the case of a 6-year-old boy diagnosed with BL, who presented multiple contrasting elements of the disease: silent symptomatology, without involvement of the bone marrow at first, but with multiorgan infiltration and a fast evolution, despite starting the treatment shortly after the symptoms appeared.
He was diagnosed with BL after immunophenotyping from the pleural fluid.
After a week from admission, chemotherapy was initiated according to protocol NH-BFM therapeutic group III-cytoreductive phase in the acute care ward and subsequently the AA 24 treatment.
Following the treatment, the patient developed medullary aplasia and cutaneous toxicity. The patient's general state remained severe during the hospitalization.
Even though the prognosis of BL has improved over time (up to 90% survival rate), in this case the evolution was unfavorable. In our patient, the symptoms appeared abruptly. They appeared late in the phase of multiple-organ dissemination, which generated the pessimistic prognosis.
伯基特淋巴瘤(BL)是一种侵袭性很强的B细胞非霍奇金淋巴瘤。它占儿童淋巴瘤病例的34%。
我们报告一例6岁男孩被诊断为BL,该病例呈现出该疾病的多个不同特征:症状隐匿,起初未累及骨髓,但出现多器官浸润且病情进展迅速,尽管在症状出现后不久就开始了治疗。
通过对胸腔积液进行免疫表型分析后,他被诊断为BL。
入院一周后,在急性护理病房按照NH - BFM治疗组III - 细胞减灭期方案开始化疗,随后进行AA 24治疗。
治疗后,患者出现骨髓再生障碍和皮肤毒性。住院期间患者的总体状况仍然很严重。
尽管随着时间推移BL的预后有所改善(生存率高达90%),但在该病例中病情进展不利。在我们的患者中,症状突然出现。它们出现在多器官播散阶段的晚期,这导致了悲观的预后。